Sept. 5, 2020
by Patrick Bailey
Biopharma insight
In the "data age," an estimated 81% of Americans own at least one smartphone. That might lead one to wonder …
July 22, 2020
by Andrii Buvailo
Interview
While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited …
July 11, 2020
by Andrii Buvailo
Biopharma insight
What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they …
July 8, 2020
by Andrii Buvailo
Biopharma insight
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …
July 2, 2020
by Andrii Buvailo
Interview
Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of …
July 1, 2020
by David Shlaes
Biopharma insight
(This post originally appeared on David Shlaes's personal blog) The US FDA just published an analysis of antibiotic development looking back …
June 19, 2020
by Irina Bilous
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological …
May 22, 2020
by Andrii Buvailo
Interview
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected …
May 12, 2020
by Andrii Buvailo
Interview
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …
May 1, 2020
by Andrii Buvailo
Interview
There is a great deal of hype and a lot of misconceptions among life science experts as to how AI …
March 23, 2020
by Rasim Shah
Biopharma insight
Moments of crisis always mean change. In these times, it’s tempting to reach for quotes from leaders who successfully navigated through turbulent …
March 20, 2020
by Nikos Tzagarakis
Biopharma insight
Tzager is an A.I. agent built for biomedicine research, drug discovery and personalized medicine, with the main features being Biochemical …